Drake Discusses CARMENA Trial and Emerging Approaches in RCC
Charles G. Drake, MD, PhD, discusses the importance of the CARMENA results, the future of cytoreductive nephrectomy, and how the use of immunotherapy could change treatment in this setting.
Source: OncLive